158 related articles for article (PubMed ID: 18826380)
21. Oral lesions in HIV-positive patients in Georgia.
Kakabadze T; Rukhadze N; Mshvidobadze K; Lomtadze M; Kandelaki G
Georgian Med News; 2008 Dec; (165):60-5. PubMed ID: 19124919
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of oral mucosal lesions and related factors in 200 HIV+/AIDS Iranian patients.
Khatibi M; Moshari AA; Jahromi ZM; Ramezankhani A
J Oral Pathol Med; 2011 Sep; 40(8):659-64. PubMed ID: 21342272
[TBL] [Abstract][Full Text] [Related]
23. Oral lesions in HIV infected individuals from Ribeirão Preto, Brazil.
Lourenço AG; Figueiredo LT
Med Oral Patol Oral Cir Bucal; 2008 May; 13(5):E281-6. PubMed ID: 18449110
[TBL] [Abstract][Full Text] [Related]
24. Oral manifestations among people living with HIV/AIDS in Tanzania.
Fabian FM; Kahabuka FK; Petersen PE; Shubi FM; Jürgensen N
Int Dent J; 2009 Aug; 59(4):187-91. PubMed ID: 19774801
[TBL] [Abstract][Full Text] [Related]
25. High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group.
Shiboski CH; Chen H; Secours R; Lee A; Webster-Cyriaque J; Ghannoum M; Evans S; Bernard D; Reznik D; Dittmer DP; Hosey L; Sévère P; Aberg JA;
PLoS One; 2015; 10(7):e0131001. PubMed ID: 26148192
[TBL] [Abstract][Full Text] [Related]
26. Oral manifestations of HIV-AIDS in Nigerian patients.
Anteyi KO; Thacher TD; Yohanna S; Idoko JI
Int J STD AIDS; 2003 Jun; 14(6):395-8. PubMed ID: 12816667
[TBL] [Abstract][Full Text] [Related]
27. Pattern of head and neck malignant neoplasms in HIV-infected patients in Kenya.
Butt FM; Chindia ML; Rana F; Machigo FG
Int J Oral Maxillofac Surg; 2008 Oct; 37(10):907-11. PubMed ID: 18783921
[TBL] [Abstract][Full Text] [Related]
28. HIV-related oral manifestations in two cohorts of women in San Francisco.
Shiboski CH; Hilton JF; Greenspan D; Westenhouse JL; Derish P; Vranizan K; Lifson AR; Canchola A; Katz MH; Cohen JB
J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):964-71. PubMed ID: 7914233
[TBL] [Abstract][Full Text] [Related]
29. [Association of oral lesions with HIV serological status].
Ramírez-Amador V; Esquivel-Pedraza L; Irigoyen-Camacho E; Anaya-Saavedra G; González-Ramírez I
Salud Publica Mex; 2002; 44(2):87-91. PubMed ID: 12053784
[TBL] [Abstract][Full Text] [Related]
30. Changes in the pattern of oral lesions associated with HIV infection: implications for dentists.
Sroussi HY; Epstein JB
J Can Dent Assoc; 2007 Dec; 73(10):949-52. PubMed ID: 18275698
[TBL] [Abstract][Full Text] [Related]
31. [Changes in immunological status among newly-diagnosed HIV-infected in Denmark 1995-2005].
Høegh S; Lohse N; Hansen AB; Gerstoft J; Kronborg G; Larsen CS; Pedersen C; Pedersen G; Laursen AL; Kvinesdal B; Møller A; Obel N
Ugeskr Laeger; 2008 Feb; 170(9):740-4. PubMed ID: 18307962
[TBL] [Abstract][Full Text] [Related]
32. Oral manifestations of HIV infection in infants: a review article.
Expósito-Delgado AJ; Vallejo-Bolaños E; Martos-Cobo EG
Med Oral Patol Oral Cir Bucal; 2004; 9(5):415-20; 410-5. PubMed ID: 15580118
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of oral lesions and percent CD4+ T-lymphocytes in HIV-infected children on antiretroviral therapy.
Okunseri C; Badner V; Wiznia A; Rosenberg M
AIDS Patient Care STDS; 2003 Jan; 17(1):5-11. PubMed ID: 12614515
[TBL] [Abstract][Full Text] [Related]
34. Risk factors of HIV-related oral lesions in adults.
Petruzzi MN; Cherubini K; Salum FG; Figueiredo MA
Rev Saude Publica; 2013 Feb; 47(1):52-9. PubMed ID: 23703130
[TBL] [Abstract][Full Text] [Related]
35. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
[TBL] [Abstract][Full Text] [Related]
36. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of oral lesions in Mexican children with perinatally acquired HIV: association with immunologic status, viral load, and gender.
Gaitán-Cepeda L; Cashat-Cruz M; Morales-Aguirre JJ; Sánchez-Vargas L; Aquino-Garcia S; Fragoso-Ríos R; Cuairán-Ruidiaz V; Avila-Figueroa C
AIDS Patient Care STDS; 2002 Apr; 16(4):151-6. PubMed ID: 12015869
[TBL] [Abstract][Full Text] [Related]
38. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP
J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
[TBL] [Abstract][Full Text] [Related]
39. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of plasma cytokines and chemokines during primary HIV-1 infection and after analytical treatment interruption.
Barqasho B; Nowak P; Tjernlund A; Kinloch S; Goh LE; Lampe F; Fisher M; Andersson J; Sönnerborg A;
HIV Med; 2009 Feb; 10(2):94-102. PubMed ID: 19200172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
